GE Healthcare and Vanderbilt University Medical Center will collaborate on enabling safer and more precise treatment of cancer immunotherapies. Under the during the five-year program, the organizations will analyze the immunotherapy treatment response of thousands of VUMC cancer patients by using anonymized demographic, genomic, tumor, cellular, proteomic and imaging data. Cancer immunotherapy is a treatment… Read More »
The Florida toddler who made international headlines last month after sparking a worldwide search for a blood donor is in need of at least three more matches as she fights aggressive cancer. Complicating the search is the 2-year-old’s genetic mutation, which means her blood is missing the “Indian B” antigen, putting the chances of finding a… Read More »
The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »
Although cervical cancer is a preventable and highly curable disease, a new report released by Human Rights Watch reveals that Black women in Alabama are dying of this cancer at more than twice the national average, reports The Guardian. Cervical cancer was once a major cause of death for American women, but the advent of… Read More »